Michael Saylors MicroStrategy A Potential Shift in Bitcoin Accumulation Strategy Qualcomm Faces Persistent Short Seller Pressure as AI Pivot Becomes Critical for Bulls Signature Global Targets Rs 5000 Crore Revenue by FY27 Despite Construction Ban Impact TeraWulf Shares Gain After Securing Over 1GW Hyperscale Data Campus in Kentucky Kazatomproms ThirdQuarter Uranium Output Rises 17 Bolstering Supply Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance Ares Management ARES Q1 2026 Earnings EPS Misses Street View but Stock Gains on Resilient Business Trends Monarch Casino Resort Inc MCRI Q1 2026 Earnings EPS Surges 349 Above Expectations PATH Q1 2026 Earnings EPS Surpasses Estimates by 155 Stock Advances YDKG Q4 2012 Earnings EPS Misses Estimates by 1422 as Stock Gains 458 Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares UZF Q1 2026 Earnings Strong EPS Surprise of 43 Drives Stock Uptick PennantPark Investment Corporation PNNT Gains 115 Approaches Key Resistance Amid Steady Volume Aethlon Medical AEMD Rallies 476 Can It Hold Above Support Arlo Technologies Inc ARLO Bounces Sharply Approaching Key Resistance Identiv Inc INVE Slips 25 as Shares Test Key Support Near 373 Calisa Acquisition Corp ALIS Holds Steady at 1006 Consolidating Near Key Resistance Chancellor Rachel Reeves Moves to Secure Position Amid Potential Labour Leadership Change SCI Q1 2026 Earnings EPS Misses Estimates Despite Stable Operations Damora Therapeutics DMRA Holds Steady Near Support Technical Analysis of Key Levels Duolingo DUOL Q1 2026 Earnings EPS Beats Estimates by 164 Amid Strong User Engagement DSGN Q1 2026 Earnings NarrowerthanExpected Loss Despite No Revenue flyExclusive Inc FLYX Q1 2026 Earnings EPS Beats Expectations Amid Positive Stock Response Mount Logan Capital Inc Q1 2026 Earnings Net Loss Reported Amidst Market Headwinds SLDE Q1 2026 Earnings EPS Beats Estimates by 174 Shares Edge Higher MLYS Q1 2026 Earnings Narrow Beat on Losses as Clinical Pipeline Progress Continues Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage